The new "broad-spectrum anticancer drugs" aim at tumor metabolizing immunotherapy! Clinical trials are on the way
-
Last Update: 2019-11-21
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
In different cancer models, jhu083 can change tumor cell metabolism and tumor microenvironment, prevent tumor growth and improve survival rate In many mice, a long-term cure can be achieved by using jhu083 alone Since metabolic therapy releases the natural anti-cancer immune response, it promotes immunotherapy When the researchers re injected the cancer free mice with new tumor cells, almost all of them did not form new tumors This shows that jhu083 treatment produces powerful immune memory, which can recognize and attack new tumors.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
